Table 2 Five-year survival outcomes of patients treated with IMRT alone and IMRT plus chemotherapy
Variable | IMRT group (n = 62) | IMRT/chemotherapy group (n = 62) | HR (95% CI) | P |
|---|---|---|---|---|
OS (%) | 1.235 (0.377–4.048) | 0.727 | ||
At 3 years | 93.5% | 91.9% | ||
At 5 years | 91.9% | 90.3% | ||
DFS (%) | 0.890 (0.323–2.453) | 0.821 | ||
At 3 years | 88.7% | 90.3% | ||
At 5 years | 87.1% | 88.7% | ||
LRRFS (%) | 1.515 (0.253–9.066) | 0.646 | ||
At 3 years | 96.8% | 95.2% | ||
At 5 years | 96.8% | 95.2% | ||
DMFS (%) | 1.037 (0.300–3.581) | 0.955 | ||
At 3 years | 93.5% | 95.2% | ||
At 5 years | 91.9% | 91.5% |